CVRx, a company out of Minneapolis, MN, received clearance in the EU for its Barostim neo carotid artery pulse stimulator to be safe for use under MRI. The device is used for certain heart failure and drug resistant hypertension patients and is being investigated for wider clinical use.
It’s implanted around the lapel under the skin like a pacemaker, with single electric lead snaked up to the carotid artery where it activates baroreceptors that in turn regulate cardiac performance. It automatically monitors cardiac activity and adjusts on every beat, can be turned off when necessary, and is programmable for each patient’s unique needs.
Here’s a video descriing the Barostim neo therapy:
Flashbacks: Barostim neo Electrical Stimulator Approved for Heart Failure in Europe (VIDEO)…; Rheos System for Hypertension Tested in New Clinical Trial…; RHEOS Device for Blood Pressure Control Undergoing New Trial…; Barostim neo Baroreflex Stimulator Receives CE Approval for Treatment of Hypertension…; Positive Results from Trial of Rheos Baroreflex Hypertension Therapy…
Product page: Barostim neo…
Press release: CVRx® Granted CE Marking of the Barostim neo System™ for Conditional MRI Compatibility…